NCT06272695View on ClinicalTrials.gov

Glucagon Rescue of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes Treated With Volagidemab

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 15, 2024

Primary Completion Date

February 1, 2025

Study Completion Date

February 1, 2025

Conditions

Type 1 Diabetes Mellitus

Interventions

BIOLOGICAL

Volagidemab

Administered by SC injection once weekly for 6 weeks

Trial Locations (2)

92037

Altman Clinical and Translational Research Institute, San Deigo

94598

Diablo Clinical Research, Walnut Creek

All Listed Sponsors

lead

REMD Biotherapeutics, Inc.

INDUSTRY

NCT06272695 - Glucagon Rescue of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes Treated With Volagidemab | Biotech Hunter | Biotech Hunter